Skip To Main Content
Toni-Ann Citera on Muck Rack

Toni-Ann Citera

As seen in: JD Supra, Lexology, Mondaq
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Toni-Ann

Contact Toni-Ann, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

DOJ Updates Corporate Compliance Program Guidance With a Focus on AI and Emerging Technologies | JD Supra

|
By Theodore T. Chung, Toni-Ann Citera, Karen Hewitt
| JD Supra
In Short The Situation: In September 2024, the U.S. Department of Justice ("DOJ" or "Department") announced updates to its Evaluation of Corporate Compliance Programs guidance covering three primary areas: (1) the risks of artificial intelligence ("AI") and emerging technologies; (2) data analytics for compliance program monitoring and continuous improvement; and (3) whistleblower protections.
Open in Who Shared Issue with article?

DOJ Updates Corporate Compliance Program Guidance With A Focus On AI And Emerging Technologies

|
By Theodore T. Chung, Henry Klehm III, Heather O'Shea, Toni-Ann Citera
| Mondaq
In Short The Situation: In September 2024, the U.S. Department of Justice ("DOJ" or "Department") announced updates to its Evaluation of Corporate Compliance Programs guidance covering three primary areas: (1) the risks of artificial intelligence ("AI") and emerging technologies; (2) data analytics for compliance program monitoring and continuous improvement; and (3) whistleblower protections.
Open in Who Shared Issue with article?

Canadian Drug Importation May Undermine Intellectual Property Protection | JD Supra

|
By Jennifer Chheda Ph.D, Toni-Ann Citera, Kyle Diamantas
| JD Supra
In Short The Situation: Earlier this year, Florida became the first state to receive authorization for its Section 804 Importation Program ("SIP") from the U.S. Food and Drug Administration ("FDA"). This initial step toward the legal importation of certain prescription drugs from Canada is the first of its kind, and legal challenges are likely. The Result: Florida has until January 5, 2025, to begin importing prescription drugs under its SIP.
Open in Who Shared Issue with article?
See all 16 articles